Transvesical peritoneoscopy : Initial clinical evaluation of the bladder as a portal for natural orifice translumenal endoscopic surgeryGETTMAN, Matthew T; BLUTE, Michael L.Mayo Clinic proceedings. 2007, Vol 82, Num 7, pp 843-845, issn 0025-6196, 3 p.Article

Surgical management of high risk prostate cancer : The Mayo Clinic experience : Prostate CancerBOORJIAN, Stephen A; BLUTE, Michael L.Urologic oncology. 2008, Vol 26, Num 5, pp 530-532, issn 1078-1439, 3 p.Conference Paper

Chemoprevention for prostatic carcinoma : The role of flutamide in patients with prostatic intraepithelial neoplasiaALBERTS, Steven R; BLUTE, Michael L.Urology (Ridgewood, NJ). 2001, Vol 57, Num 4A, pp 188-190, issn 0090-4295Article

Radical prostatectomy: Does surgical technique influence margin control? : Positive surgical margins at radical prostatectomy: Do they really matter ?GETTMAN, Matthew T; BLUTE, Michael L.Urologic oncology. 2010, Vol 28, Num 2, pp 219-225, issn 1078-1439, 7 p.Article

T2 clear cell renal cell carcinoma is a rare entity : A study of 120 clear cell renal cell carcinomas. CommentaryBONSIB, Stephen M; BLUTE, Michael L.The Journal of urology. 2005, Vol 174, Num 4, pp 1199-1202, issn 0022-5347, 4 p., 1Article

Update on pathologic staging of renal cell carcinomaGETTMAN, Matthew T; BLUTE, Michael L.Urology (Ridgewood, NJ). 2002, Vol 60, Num 2, pp 209-217, issn 0090-4295Article

Surgical management of renal cell carcinomaLEIBOVICH, Bradley C; BLUTE, Michael L.Seminars in oncology. 2006, Vol 33, Num 5, pp 552-562, issn 0093-7754, 11 p.Article

Prostate Specific Antigen Kinetics in the Management of Prostate CancerSENGUPTA, Shomik; AMLING, Christopher; D'AMICO, Anthony V et al.The Journal of urology. 2008, Vol 179, Num 3, pp 821-826, issn 0022-5347, 6 p.Article

Surgical treatment of stage pT3b renal cell carcinoma in solitary kidneys : a case seriesSENGUPTA, Shomik; ZINCKE, Horst; LEIBOVICH, Bradley C et al.BJU international (Papier). 2005, Vol 96, Num 1, pp 54-57, issn 1464-4096, 4 p.Article

Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancerZINCKE, Horst; LAU, Weber; BERGSTRALH, Erik et al.The Journal of urology. 2001, Vol 166, Num 6, pp 2208-2215, issn 0022-5347Article

Renal nephrometry score is associated with urine leak after partial nephrectomyBRUNER, Bryan; BREAU, Rodney H; LOHSE, Christine M et al.BJU international (Papier). 2011, Vol 108, Num 1, pp 67-72, issn 1464-4096, 6 p.Article

Simple graphic method for estimation of prostate-specific antigen doubling timeSENGUPTA, Shomik; SLEZAK, Jeffrey M; BLUTE, Michael L et al.Urology (Ridgewood, NJ). 2006, Vol 67, Num 2, pp 408-409, issn 0090-4295, 2 p.Article

Salvage surgery for radiorecurrent prostate cancer : Contemporary outcomesWARD, John F; SEBO, Thomas J; BLUTE, Michael L et al.The Journal of urology. 2005, Vol 173, Num 4, pp 1156-1160, issn 0022-5347, 5 p.Article

Use of gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomyBLUTE, Michael L; BERGSTRALH, Erik J; IOCCA, Angelo et al.The Journal of urology. 2001, Vol 165, Num 1, pp 119-125, issn 0022-5347Article

Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing : 15-year outcomeWARD, John F; SLEZAK, Jeffrey M; BLUTE, Michael L et al.BJU international (Papier). 2005, Vol 95, Num 6, pp 751-756, issn 1464-4096, 6 p.Article

Tissue ablation technologies for localized prostate cancerGILLETT, Michael D; GETTMAN, Matthew T; ZINCKE, Horst et al.Mayo Clinic proceedings. 2004, Vol 79, Num 12, pp 1547-1555, issn 0025-6196, 9 p.Article

Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinomaCHEVILLE, John C; LOHSE, Christine M; ZINCKE, Horst et al.The American journal of surgical pathology. 2003, Vol 27, Num 5, pp 612-624, issn 0147-5185, 13 p.Article

Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidneyELLIOTT, Daniel S; SEGURA, Joseph W; LIGHTNER, Deborah et al.Urology (Ridgewood, NJ). 2001, Vol 58, Num 2, pp 174-178, issn 0090-4295Article

Lifelong Yearly Prostate Specific Antigen Surveillance is Not Necessary for Low Risk Prostate Cancer Treated With Radical ProstatectomyTOLLEFSON, Matthew K; BLUTE, Michael L; RANGEL, Laureano J et al.The Journal of urology. 2010, Vol 184, Num 3, pp 925-929, issn 0022-5347, 5 p.Article

Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomyTOLLEFSON, Matthew K; SLEZAK, Jeffrey M; LEIBOVICH, Bradley C et al.Mayo Clinic proceedings. 2007, Vol 82, Num 4, pp 422-427, issn 0025-6196, 6 p.Article

Minimally Invasive radical prostatectomyHUMPHREYS, Mitchell R; GETTMAN, Matthew T; CHOW, George K et al.Mayo Clinic proceedings. 2004, Vol 79, Num 9, pp 1169-1180, issn 0025-6196, 12 p.Article

Ureteroscopy: Effect of technology and technique on clinical practiceCHOW, George K; PATTERSON, David E; BLUTE, Michael L et al.The Journal of urology. 2003, Vol 170, Num 1, pp 99-102, issn 0022-5347, 4 p.Article

The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomyWARD, John F; BLUTE, Michael L; SLEZAK, Jeffrey et al.The Journal of urology. 2003, Vol 170, Num 5, pp 1872-1876, issn 0022-5347, 5 p.Article

Pathologic staging of renal cell carcinoma: Significance of tumor classification with the 1997 TNM Staging SystemGETTMAN, Matthew T; BLUTE, Michael L; SPOTTS, Bruce et al.Cancer. 2001, Vol 91, Num 2, pp 354-361, issn 0008-543XConference Paper

Long-term prognostic significance of primary gleason pattern in patients with gleason score 7 prostate cancer : Impact on prostate cancer specific survivalTOLLEFSON, Matthew K; LEIBOVICH, Bradley C; SLEZAK, Jeffrey M et al.The Journal of urology. 2006, Vol 175, Num 2, pp 547-551, issn 0022-5347, 5 p.Article